|
Call for Abstracts
|
|
Abstract submissions for the 4th SHSA will be open on March 1, 2019. Only online submissions will be accepted for consideration of oral or poster presentations.
Important Deadlines:
Call for Abstracts opens |
March 2019 |
Online registration opens |
March 2019 |
Abstract submission deadline |
July 5, 2019 |
Notice of Abstract adjudication |
July 22, 2019 |
Deadline for presenting authors to register |
August 30, 2019 |
Early registration deadline |
August 30, 2019 |
Hotel booking deadline (based on availability) |
October 1, 2019 |
Abstract Format
Please indicate your preference for oral or poster presentation in the online submission. Due to the limited number of oral presentations available in the SHSA program, meritorious abstracts not assigned to oral presentation, will be accepted for posters. Please indicate in the online submission system if you do not wish to accept a poster presentation in this instance.
An acknowledgement of your abstract submission(s) will be sent via email.
Abstracts will be peer reviewed, following the submission deadline on Friday, July 5, 2019. Notifications will be sent to the accepted abstract submitters by Monday, July 22, 2019. Correspondence will be directed to the submitting author.
Topics
Please submit your abstract by selecting one category out of the following that best describes its scientific content. Categories will be used for reviewing and indexing purposes.
Disclosure of Conflict
Authors are required to complete a Disclosure of Conflict form as part of the abstract submission. These will be included in the Final Program. Abstracts must be free of commercial bias and should only identify drug products by their generic names.
Condition of Acceptance
A condition of acceptance is that you must register for the conference. Conference registration must be received by Friday, August 30 in order for the abstract to be included in the program.
Please indicate your preference for oral or poster presentation in the online submission. Due to the limited number of oral presentations available in the SHSA program, meritorious abstracts not assigned to oral presentation, will be accepted for posters. Please indicate in the online submission system if you do not wish to accept a poster presentation in this instance.
An acknowledgement of your abstract submission(s) will be sent via email.
Abstracts will be peer reviewed, following the submission deadline on Friday, July 5, 2019. Notifications will be sent to the accepted abstract submitters by Monday, July 22, 2019. Correspondence will be directed to the submitting author.
Topics
Please submit your abstract by selecting one category out of the following that best describes its scientific content. Categories will be used for reviewing and indexing purposes.
- Epidemiology and Health Services Research
- Clinical Research including Quality of Life
- Comorbidities and complications
- Clinical trial research & innovation
- Basic & Translational research
- Medical treatments and wound care
- Surgical and interventional treatments
Disclosure of Conflict
Authors are required to complete a Disclosure of Conflict form as part of the abstract submission. These will be included in the Final Program. Abstracts must be free of commercial bias and should only identify drug products by their generic names.
Condition of Acceptance
A condition of acceptance is that you must register for the conference. Conference registration must be received by Friday, August 30 in order for the abstract to be included in the program.
Abstract Submission Process
Abstracts submissions will be accepted via the online submission system only by clicking on the "Online Submission" above. Abstracts sent by email or mail will not be accepted.
All abstracts submitted must select from one of the conference topics for inclusion in the program. Abstracts should present new information, and not have been submitted or published elsewhere (at the time of submission). When submitting an abstract, please select the topic that best applies to your abstract. Topics can be selected from the drop-down menu of the online submission system.
Submitting authors and/or presenters may modify their submission(s) until the closing date of July 5, 2019 at 5:00pm PST.
Abstracts selected for poster or oral presentations in the 4th Annual Symposium on HS Advances will be reproduced exactly as submitted and substitutions will not be permitted. Be sure to proofread your abstract very carefully before submitting. All accepted abstracts will be published in the Journal of Experimental Dermatology as a proceeding report with your name.
Abstract Guidelines
2. Methods, Results
3. Conclusions
Travel Grants
The Organizing Committee of the Symposium on HS Advances anticipates a limited number of travel grants will be available. The awards are for junior investigators (within 10 years of completion of training), residents, fellows, post-docs, professional and graduate students with a demonstrated interest in HS.
Candidates from all countries will be considered. To be eligible, applicants must be the presenter of an accepted abstract. In planning travel that is eligible for travel grant reimbursement, travel expenses that will qualify for reimbursement by the grant include: (a) Coach airfare travel on a U. S. flag air carrier; or (b) driving a personal vehicle [must be less than 750 miles roundtrip]; or (c) train or bus travel. Hotel can be booked and will be reimbursed up to the travel award amount after the conference.
Travel Grant recipients must pay the SHSA Registration Fee. Registration costs are not covered by the travel award.
To apply, please select the Travel Grant tick box in the online abstract submission.
CHSF Trainee Scholarships
In addition to the SHSA Travel Grants, the Canadian HS Foundation is pleased to announce that three trainee scholarships ($1,000 CAD each) are available to Canadian dermatology residents or fellows who are the presenters of an accepted abstract at the 4th Annual Symposium on Hidradenitis Suppurativa Advances. Please note, the CHSF Trainee Scholarships are managed directly by the CHSF. For more information or to apply for the scholarship, please contact pbelfer@dermatology.ca
Deadline for applying – August 23, 2019
Abstracts submissions will be accepted via the online submission system only by clicking on the "Online Submission" above. Abstracts sent by email or mail will not be accepted.
All abstracts submitted must select from one of the conference topics for inclusion in the program. Abstracts should present new information, and not have been submitted or published elsewhere (at the time of submission). When submitting an abstract, please select the topic that best applies to your abstract. Topics can be selected from the drop-down menu of the online submission system.
Submitting authors and/or presenters may modify their submission(s) until the closing date of July 5, 2019 at 5:00pm PST.
Abstracts selected for poster or oral presentations in the 4th Annual Symposium on HS Advances will be reproduced exactly as submitted and substitutions will not be permitted. Be sure to proofread your abstract very carefully before submitting. All accepted abstracts will be published in the Journal of Experimental Dermatology as a proceeding report with your name.
Abstract Guidelines
- Prepare your abstract in MS Word
- Do not use presentation software, such as PowerPoint
- Limit your abstract (body) to no more than 300 words
- It is suggested, other than case presentations, to separate your abstract into three (3) paragraphs:
2. Methods, Results
3. Conclusions
- Include learning objectives and a takeaway message.
Travel Grants
The Organizing Committee of the Symposium on HS Advances anticipates a limited number of travel grants will be available. The awards are for junior investigators (within 10 years of completion of training), residents, fellows, post-docs, professional and graduate students with a demonstrated interest in HS.
Candidates from all countries will be considered. To be eligible, applicants must be the presenter of an accepted abstract. In planning travel that is eligible for travel grant reimbursement, travel expenses that will qualify for reimbursement by the grant include: (a) Coach airfare travel on a U. S. flag air carrier; or (b) driving a personal vehicle [must be less than 750 miles roundtrip]; or (c) train or bus travel. Hotel can be booked and will be reimbursed up to the travel award amount after the conference.
Travel Grant recipients must pay the SHSA Registration Fee. Registration costs are not covered by the travel award.
To apply, please select the Travel Grant tick box in the online abstract submission.
CHSF Trainee Scholarships
In addition to the SHSA Travel Grants, the Canadian HS Foundation is pleased to announce that three trainee scholarships ($1,000 CAD each) are available to Canadian dermatology residents or fellows who are the presenters of an accepted abstract at the 4th Annual Symposium on Hidradenitis Suppurativa Advances. Please note, the CHSF Trainee Scholarships are managed directly by the CHSF. For more information or to apply for the scholarship, please contact pbelfer@dermatology.ca
Deadline for applying – August 23, 2019